Marcy P Y, Laurent F, Cazenave F, Drouillard J, Chevallier P, Gorin G, Maestro C, Grelet P, Bruneton J N
Centre Antoine-Lacassagne, Nice.
J Radiol. 1997 Mar;78(3):209-14.
Twenty-three patients with SVC syndrome were evaluated with CT and venography. The superior vena cava or its tributaries were either stenosed or thrombosed. The etiology was malignant in all cases: non small cell carcinoma (16 cases), mediastinal nodal metastasis (3 cases), lymphomas (2 cases), pleural mesothelioma (1 case), small cell carcinoma (1 case). The length of the stenosis ranged from 20 to 70 mm. The stents were placed via a femoral, jugular or brachial approach. Stenting was achieved in 22/23 patients (96%). Clinical symptoms subsided in 20/22 patients (87%). Mean follow-up was 15 weeks. Stents remained patent in 17/20 patients (78%). Stenting is a safe and effective treatment of SVC syndrome in patients with malignant conditions.
对23例上腔静脉综合征患者进行了CT和静脉造影评估。上腔静脉及其属支出现狭窄或血栓形成。所有病例的病因均为恶性：非小细胞癌（16例）、纵隔淋巴结转移（3例）、淋巴瘤（2例）、胸膜间皮瘤（1例）、小细胞癌（1例）。狭窄长度为20至70毫米。通过股动脉、颈静脉或肱动脉途径置入支架。23例患者中有22例（96%）成功置入支架。22例患者中有20例（87%）临床症状缓解。平均随访15周。20例患者中有17例（78%）支架保持通畅。对于患有恶性疾病的上腔静脉综合征患者，支架置入术是一种安全有效的治疗方法。
